Millipore and Gen-Probe collaboration expanded

Millipore is to extend its collaboration with Gen-Probe based on the creation of a new generation of nucleic acid tests aimed at the biopharmaceutical market.

The scientific product manufacturer announced at the BIO 2007 International Convention that it will market and sell Gen-Probe’s Mycoplasma Tissue Culture Non-Isotopic (MTC-NI) test.

Originally developed by Gen-Probe, the MTC-NI assay is a DNA probe-based system that can be combined with Millipore’s sample preparation products to detect mycoplasma.

Jean-Paul Mangeolle, president of Millipore’s Bioprocess division, commented: "The expansion of our partnership with Gen-Probe reflects our conviction in the long-term potential for developing faster and more accurate detection of microorganisms in biopharmaceutical production.

"As we are developing these new assays, it is extremely valuable to have the ability to sell Gen-Probe’s MTC-NI tests to many of the same customers who we believe will eventually purchase the new tests we are developing."

Millipore’s Bioprocess Division aims to optimise laboratory productivity and workflows through the provision of enabling technologies for life science research and development.

The manufacturer recently reported that first quarter revenues increased by 39 per cent.